{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:34:52Z","timestamp":1793720092430,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Basic Research Project of Yantai Science and Technology Innovation and Development Plan","award":["2022JCYJ026"],"award-info":[{"award-number":["2022JCYJ026"]}]},{"name":"The Basic Research Project of Yantai Science and Technology Innovation and Development Plan","award":["2023JCYJ068"],"award-info":[{"award-number":["2023JCYJ068"]}]},{"name":"The Natural Science Foundation of Shandong province","award":["ZR202111250163"],"award-info":[{"award-number":["ZR202111250163"]}]},{"name":"College Students\u2019 innovation and entrepreneurship training program","award":["S202310440040"],"award-info":[{"award-number":["S202310440040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05621-w","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T11:04:34Z","timestamp":1730113474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["VEGFB ameliorates insulin resistance in NAFLD via the PI3K\/AKT signal pathway"],"prefix":"10.1186","volume":"22","author":[{"given":"Yuqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meizi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"issue":"6","key":"5621_CR1","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1002\/hep.31568","volume":"73","author":"Q Lin","year":"2021","unstructured":"Lin Q, Huang Z, Cai G, Fan X, Yan X, Liu Z, et al. Activating Adenosine Monophosphate-activated protein kinase mediates fibroblast growth factor 1 Protection from nonalcoholic fatty liver disease in mice. Hepatology. 2021;73(6):2206\u201322.","journal-title":"Hepatology"},{"issue":"2","key":"5621_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","volume":"49","author":"E Cobbina","year":"2017","unstructured":"Cobbina E, Akhlaghi F. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev. 2017;49(2):197\u2013211.","journal-title":"Drug Metab Rev"},{"issue":"5","key":"5621_CR3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","volume":"40","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Miotto PM, De Nardo W, Montgomery MK. The liver as an endocrine organ-linking NAFLD and insulin resistance. Endocr Rev. 2019;40(5):1367\u201393.","journal-title":"Endocr Rev"},{"key":"5621_CR4","doi-asserted-by":"crossref","unstructured":"Saltiel AR. Insulin signaling in health and disease. J Clin Invest. 2021;131(1).","DOI":"10.1172\/JCI142241"},{"issue":"1","key":"5621_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2017","unstructured":"Tilg H, Moschen AR, Roden M. NAFLD and Diabetes Mellitus. Nat Rev Gastroenterol Hepatol. 2017;14(1):32\u201342.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"5621_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molmed.2011.11.006","volume":"18","author":"X Li","year":"2012","unstructured":"Li X, Kumar A, Zhang F, Lee C, Tang Z. Complicated life, complicated VEGF-B. Trends Mol Med. 2012;18(2):119\u201327.","journal-title":"Trends Mol Med"},{"issue":"4","key":"5621_CR7","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cmet.2016.03.004","volume":"23","author":"MR Robciuc","year":"2016","unstructured":"Robciuc MR, Kivela R, Williams IM, de Boer JF, van Dijk TH, Elamaa H, et al. VEGFB\/VEGFR1-Induced expansion of adipose vasculature counteracts obesity and related metabolic complications. Cell Metab. 2016;23(4):712\u201324.","journal-title":"Cell Metab"},{"key":"5621_CR8","doi-asserted-by":"publisher","first-page":"119401","DOI":"10.1016\/j.lfs.2021.119401","volume":"276","author":"L Hu","year":"2021","unstructured":"Hu L, Shan Z, Wang F, Gao X, Tong Y. Vascular endothelial growth factor B exerts lipid-lowering effect by activating AMPK via VEGFR1. Life Sci. 2021;276:119401.","journal-title":"Life Sci"},{"issue":"1","key":"5621_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.apsb.2020.07.002","volume":"11","author":"Y Shen","year":"2021","unstructured":"Shen Y, Chen W, Han L, Bian Q, Fan J, Cao Z, et al. VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses. Acta Pharm Sin B. 2021;11(1):127\u201342.","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"5621_CR10","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang X, Liu G, Guo J, Su Z. The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14(11):1483\u201396.","journal-title":"Int J Biol Sci"},{"key":"5621_CR11","doi-asserted-by":"publisher","first-page":"585860","DOI":"10.3389\/fphar.2020.585860","volume":"11","author":"D Wu","year":"2020","unstructured":"Wu D, Zhong P, Wang Y, Zhang Q, Li J, Liu Z, et al. Hydrogen Sulfide attenuates high-Fat Diet-Induced non-alcoholic fatty liver disease by inhibiting apoptosis and promoting autophagy via reactive oxygen Species\/Phosphatidylinositol 3-Kinase\/AKT\/Mammalian target of Rapamycin Signaling Pathway. Front Pharmacol. 2020;11:585860.","journal-title":"Front Pharmacol"},{"key":"5621_CR12","doi-asserted-by":"publisher","first-page":"12977","DOI":"10.1038\/ncomms12977","volume":"7","author":"N Kubota","year":"2016","unstructured":"Kubota N, Kubota T, Kajiwara E, Iwamura T, Kumagai H, Watanabe T, et al. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity. Nat Commun. 2016;7:12977.","journal-title":"Nat Commun"},{"key":"5621_CR13","doi-asserted-by":"publisher","first-page":"2940746","DOI":"10.1155\/2020\/2940746","volume":"2020","author":"M Jin","year":"2020","unstructured":"Jin M, Feng H, Wang Y, Yan S, Shen B, Li Z, et al. Gentiopicroside ameliorates oxidative stress and lipid Accumulation through Nuclear factor erythroid 2-Related factor 2 activation. Oxid Med Cell Longev. 2020;2020:2940746.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"5621_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bone.2011.06.034","volume":"50","author":"S Kousteni","year":"2012","unstructured":"Kousteni S. FoxO1, the transcriptional chief of staff of energy metabolism. Bone. 2012;50(2):437\u201343.","journal-title":"Bone"},{"issue":"2","key":"5621_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00125-014-3451-1","volume":"58","author":"B Thorens","year":"2015","unstructured":"Thorens B. GLUT2, glucose sensing and glucose homeostasis. Diabetologia. 2015;58(2):221\u201332.","journal-title":"Diabetologia"},{"issue":"6","key":"5621_CR16","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/hep.32589","volume":"76","author":"AM Shearer","year":"2022","unstructured":"Shearer AM, Wang Y, Fletcher EK, Rana R, Michael ES, Nguyen N, et al. PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and akt interference. Hepatology. 2022;76(6):1778\u201393.","journal-title":"Hepatology"},{"issue":"1","key":"5621_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12967-022-03540-2","volume":"20","author":"R Li","year":"2022","unstructured":"Li R, Li Y, Yang X, Hu Y, Yu H, Li Y. Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathway. J Transl Med. 2022;20(1):341.","journal-title":"J Transl Med"},{"issue":"9","key":"5621_CR18","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1002\/art.11232","volume":"48","author":"AW Mould","year":"2003","unstructured":"Mould AW, Tonks ID, Cahill MM, Pettit AR, Thomas R, Hayward NK, et al. Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis Rheum. 2003;48(9):2660\u20139.","journal-title":"Arthritis Rheum"},{"issue":"7420","key":"5621_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nature11464","volume":"490","author":"CE Hagberg","year":"2012","unstructured":"Hagberg CE, Mehlem A, Falkevall A, Muhl L, Fam BC, Ortsater H, et al. Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes. Nature. 2012;490(7420):426\u201330.","journal-title":"Nature"},{"issue":"6","key":"5621_CR20","doi-asserted-by":"publisher","first-page":"E753","DOI":"10.1152\/ajpendo.00219.2021","volume":"321","author":"S Rui","year":"2021","unstructured":"Rui S, Nathaniel L, Chae SL, Yajie Z, Karanjit P, Oscar S. Cardiac-specific VEGFB overexpression reduces lipoprotein lipase activity 2 and improves insulin action in rat heart. Am J Physiol Endocrinol Metab. 2021;321(6):E753\u201365.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"5621_CR21","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1038\/s41366-022-01212-1","volume":"46","author":"A Lago-Sampedro","year":"2022","unstructured":"Lago-Sampedro A, Lhamyani S, Valdes S, Colomo N, Maldonado-Araque C, Gonzalez-Molero I, et al. Serum vascular endothelial growth factor b and metabolic syndrome incidence in the population based cohort Di@bet.es study. Int J Obes (Lond). 2022;46(11):2013\u201320.","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"5621_CR22","doi-asserted-by":"publisher","first-page":"786","DOI":"10.4254\/wjh.v15.i6.786","volume":"15","author":"Y Li","year":"2023","unstructured":"Li Y, Xin L, Zhao YC, Li SQ, Li YN. Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value. World J Hepatol. 2023;15(6):786\u201396.","journal-title":"World J Hepatol"},{"issue":"26","key":"5621_CR23","doi-asserted-by":"publisher","first-page":"6772","DOI":"10.1021\/acs.jafc.8b01831","volume":"66","author":"Y Zang","year":"2018","unstructured":"Zang Y, Fan L, Chen J, Huang R, Qin H. Improvement of lipid and glucose metabolism by Capsiate in Palmitic Acid-treated HepG2 cells via activation of the AMPK\/SIRT1 Signaling Pathway. J Agric Food Chem. 2018;66(26):6772\u201381.","journal-title":"J Agric Food Chem"},{"issue":"2","key":"5621_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","volume":"227","author":"AP DeFilippis","year":"2013","unstructured":"DeFilippis AP, Blaha MJ, Martin SS, Reed RM, Jones SR, Nasir K, et al. Nonalcoholic fatty liver disease and serum lipoproteins: the multi-ethnic study of atherosclerosis. Atherosclerosis. 2013;227(2):429\u201336.","journal-title":"Atherosclerosis"},{"key":"5621_CR25","first-page":"1186","volume":"19","author":"X Ye","year":"2020","unstructured":"Ye X, Kong W, Zafar MI, Zeng J, Yang R, Chen LL. Plasma vascular endothelial growth factor B is elevated in non-alcoholic fatty liver disease patients and associated with blood pressure and renal dysfunction. EXCLI J. 2020;19:1186\u201395.","journal-title":"EXCLI J"},{"issue":"11","key":"5621_CR26","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1017\/S0265021507001111","volume":"24","author":"U Holzinger","year":"2007","unstructured":"Holzinger U, Kitzberger R, Fuhrmann V, Funk GC, Madl C, Ratheiser K. Correlation of calculated indices of insulin resistance (QUICKI and HOMA) with the euglycaemic hyperinsulinaemic clamp technique for evaluating insulin resistance in critically ill patients. Eur J Anaesthesiol. 2007;24(11):966\u201370.","journal-title":"Eur J Anaesthesiol"},{"issue":"10","key":"5621_CR27","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364.","journal-title":"Cell"},{"issue":"1","key":"5621_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","volume":"27","author":"VT Samuel","year":"2018","unstructured":"Samuel VT, Shulman GI. Nonalcoholic fatty liver disease as a Nexus of metabolic and hepatic diseases. Cell Metab. 2018;27(1):22\u201341.","journal-title":"Cell Metab"},{"issue":"6","key":"5621_CR29","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.cmet.2019.03.010","volume":"29","author":"A Molinaro","year":"2019","unstructured":"Molinaro A, Becattini B, Mazzoli A, Bleve A, Radici L, Maxvall I, et al. Insulin-driven PI3K-AKT signaling in the hepatocyte is mediated by redundant PI3Kalpha and PI3Kbeta activities and is promoted by RAS. Cell Metab. 2019;29(6):1400\u20139. e5.","journal-title":"Cell Metab"},{"issue":"1","key":"5621_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2119\/molmed.2014.00240","volume":"21","author":"J Wang","year":"2015","unstructured":"Wang J, Liu B, Han H, Yuan Q, Xue M, Xu F, et al. Acute hepatic insulin resistance contributes to hyperglycemia in rats following myocardial infarction. Mol Med. 2015;21(1):68\u201376.","journal-title":"Mol Med"},{"issue":"1","key":"5621_CR31","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-17-0151","volume":"60","author":"J Peng","year":"2018","unstructured":"Peng J, He L. IRS posttranslational modifications in regulating insulin signaling. J Mol Endocrinol. 2018;60(1):R1\u20138.","journal-title":"J Mol Endocrinol"},{"issue":"9","key":"5621_CR32","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41366-018-0062-9","volume":"42","author":"M Honma","year":"2018","unstructured":"Honma M, Sawada S, Ueno Y, Murakami K, Yamada T, Gao J, et al. Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers. Int J Obes (Lond). 2018;42(9):1544\u201355.","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"5621_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2165\/00003495-198733020-00004","volume":"33","author":"G M Ward","year":"1987","unstructured":"G M Ward. The insulin receptor concept and its relation to the treatment of diabetes. Drugs. 1987;33(2):156\u201370.","journal-title":"Drugs"},{"issue":"3","key":"5621_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bbrc.2008.07.121","volume":"375","author":"R Roskoski","year":"2008","unstructured":"Roskoski R. Jr. VEGF receptor protein-tyrosine kinases: structure and regulation. Biochem Biophys Res Commun. 2008;375(3):287\u201391.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"5621_CR35","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte RS, Chen DS, Ferrara N. VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019;176(6):1248\u201364.","journal-title":"Cell"},{"key":"5621_CR36","doi-asserted-by":"publisher","first-page":"100954","DOI":"10.1016\/j.preteyeres.2021.100954","volume":"84","author":"A Uemura","year":"2021","unstructured":"Uemura A, Fruttiger M, D\u2019Amore PA, De Falco S, Joussen AM, Sennlaub F, et al. VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog Retin Eye Res. 2021;84:100954.","journal-title":"Prog Retin Eye Res"},{"key":"5621_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41540-017-0037-9","volume":"4","author":"JC Weddell","year":"2018","unstructured":"Weddell JC, Chen S, Imoukhuede PI. VEGFR1 promotes cell migration and proliferation through PLCgamma and PI3K pathways. NPJ Syst Biol Appl. 2018;4:1.","journal-title":"NPJ Syst Biol Appl"},{"key":"5621_CR38","doi-asserted-by":"publisher","first-page":"40582","DOI":"10.1038\/srep40582","volume":"7","author":"G Di","year":"2017","unstructured":"Di G, Zhao X, Qi X, Zhang S, Feng L, Shi W, et al. VEGF-B promotes recovery of corneal innervations and trophic functions in diabetic mice. Sci Rep. 2017;7:40582.","journal-title":"Sci Rep"},{"issue":"1","key":"5621_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13046-018-0980-3","volume":"37","author":"S Duan","year":"2018","unstructured":"Duan S, Huang W, Liu X, Liu X, Chen N, Xu Q, et al. IMPDH2 promotes colorectal cancer progression through activation of the PI3K\/AKT\/mTOR and PI3K\/AKT\/FOXO1 signaling pathways. J Exp Clin Cancer Res. 2018;37(1):304.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"5621_CR40","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrendo.2017.80","volume":"13","author":"MC Petersen","year":"2017","unstructured":"Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol. 2017;13(10):572\u201387.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"5621_CR41","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/med.21867","volume":"42","author":"L Wang","year":"2022","unstructured":"Wang L, Li J, Di LJ. Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases. Med Res Rev. 2022;42(2):946\u201382.","journal-title":"Med Res Rev"},{"issue":"5","key":"5621_CR42","doi-asserted-by":"publisher","first-page":"E985","DOI":"10.1152\/ajpendo.00004.2009","volume":"296","author":"A Leturque","year":"2009","unstructured":"Leturque A, Brot-Laroche E, Le Gall M. GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab. 2009;296(5):E985\u201392.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"5621_CR43","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1017\/S1462399411002109","volume":"14","author":"SM Schultze","year":"2012","unstructured":"Schultze SM, Hemmings BA, Niessen M, Tschopp O. PI3K\/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert Rev Mol Med. 2012;14:e1.","journal-title":"Expert Rev Mol Med"},{"issue":"34","key":"5621_CR44","doi-asserted-by":"publisher","first-page":"40354","DOI":"10.1021\/acsami.1c11468","volume":"13","author":"Y Li","year":"2021","unstructured":"Li Y, Tang Y, Shi S, Gao S, Wang Y, Xiao D, et al. Tetrahedral Framework nucleic acids ameliorate insulin resistance in type 2 diabetes Mellitus via the PI3K\/Akt Pathway. ACS Appl Mater Interfaces. 2021;13(34):40354\u201364.","journal-title":"ACS Appl Mater Interfaces"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05621-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05621-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05621-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T22:05:43Z","timestamp":1730153143000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05621-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5621"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05621-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4341389\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the animal ethics committee of Binzhou Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the content and agree to submit for consideration for publication in the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The manuscript has been read and approved by all authors. The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"976"}}